Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Nov 2 - Nov 7
Another vital step is monitoring your blood sugar levels regularly
Work with someone whos fluent in perimenopause and hormone optimization, not just weight loss
Clinical trials show average reductions of 15% body weight with semaglutide and 22.5% with tirzepatide over 1672 weeks
The top dose produced 20.9% average weight loss over 72 weeks and 20.2% in a direct comparison with semaglutides 13.7%. Its second receptor, GIP, separates tirzepatide from approved single-receptor GLP-1 drugs and helps explain the larger population-level weight loss. That 20.9% came from participants averaging about 105 kg at a BMI of 38, most of whom were sedentary
It includes records from millions of patients across large healthcare organizations
